| scholarly article | Q13442814 |
| P2093 | author name string | R. P. Levine | |
| M. Achtman | |||
| G. Pluschke | |||
| J. Mayden | |||
| P2860 | cites work | Serology, chemistry, and genetics of O and K antigens of Escherichia coli | Q24564133 |
| Pathogenesis of neonatal Escherichia coli meningitis: induction of bacteremia and meningitis in infant rats fed E. coli K1 | Q34429298 | ||
| Properdin factor D: characterization of its active site and isolation of the precursor form | Q36272890 | ||
| Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types. | Q36344047 | ||
| Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane | Q36346256 | ||
| Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death | Q36346273 | ||
| Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells | Q37586846 | ||
| Requirement for an additional serum factor essential for the antibody-independent activation of the classical complement sequence by Gram-negative bacteria. | Q40598409 | ||
| Six widespread bacterial clones among Escherichia coli K1 isolates. | Q40599761 | ||
| Further characterization of complement resistance conferred on Escherichia coli by the plasmid genes traT of R100 and iss of ColV,I-K94. | Q40612961 | ||
| Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis | Q40877593 | ||
| Antibody-independent interaction of the first component of complement with Gram-negative bacteria | Q40911774 | ||
| Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity | Q40968351 | ||
| Transfer of Humoral Secretory and Cellular Immunity from Mother to Offspring | Q41551444 | ||
| The bactericidal effect of normal human serum on E. coli strains from normals and from patients with urinary tract infections | Q44037673 | ||
| Antibody-independent interactions between Escherichia coli J5 and human complement components. | Q46898498 | ||
| Properties of a new complement-dependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice | Q50212932 | ||
| Restriction of alternative complement pathway activation by sialosylglycolipids | Q59086305 | ||
| Sepsis neonatorum | Q67259625 | ||
| Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b | Q67469494 | ||
| Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis | Q70014651 | ||
| The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity | Q70168950 | ||
| Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes | Q72754457 | ||
| How complement kills E. coli. I. Location of the lethal lesion | Q72903057 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiology | Q7193 |
| Escherichia coli | Q25419 | ||
| immunology | Q101929 | ||
| P304 | page(s) | 907-913 | |
| P577 | publication date | 1983-12-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing | |
| P478 | volume | 42 |
| Q36699790 | A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies |
| Q36315394 | A new O-antigen gene cluster has a key role in the virulence of the Escherichia coli meningitis clone O45:K1:H7 |
| Q42789654 | Acquisition of genes from an O18:K1:H7 ColV+ strain of Escherichia coli renders intracranially-inoculated E. coli K12 highly virulent for chickens, ducks and guinea-pigs but not mice |
| Q40170647 | Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1. |
| Q57802480 | Bacterial infections and cancer |
| Q35033785 | Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide |
| Q40374199 | C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins |
| Q40152443 | Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity |
| Q38313376 | Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates. |
| Q34796849 | Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups. |
| Q39572839 | Comparison of loss of serum resistance by defined lipopolysaccharide mutants and an acapsular mutant of uropathogenic Escherichia coli O75:K5. |
| Q38342684 | Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis |
| Q40181929 | Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns |
| Q35221012 | Development of a serotype-specific DNA microarray for identification of some Shigella and pathogenic Escherichia coli strains |
| Q39404763 | Discovery and characterization of de novo sialic acid biosynthesis in the phylum Fusobacterium |
| Q36272183 | Disruption of the M949_RS01915 gene changed the bacterial lipopolysaccharide pattern, pathogenicity and gene expression of Riemerella anatipestifer |
| Q90560370 | Drivers and regulators of humoral innate immune responses to infection and cancer |
| Q35472569 | Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice |
| Q39573882 | Environmental growth conditions influence the ability of Escherichia coli K1 to invade brain microvascular endothelial cells and confer serum resistance |
| Q36250298 | Escherichia coli in extra-intestinal infections |
| Q28817422 | Evidence for a LOS and a capsular polysaccharide in Capnocytophaga canimorsus |
| Q47861434 | Genome-Wide Identification by Transposon Insertion Sequencing of Escherichia coli K1 Genes Essential for in vitro Growth, Gastrointestinal Colonizing Capacity and Survival in Serum |
| Q30316854 | Genomic avenue to avian colisepticemia |
| Q52576392 | Glycointeractions in bacterial pathogenesis. |
| Q39284859 | How Escherichia coli Circumvent Complement-Mediated Killing. |
| Q35822718 | Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria |
| Q33619365 | Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). |
| Q58577394 | Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins |
| Q39828417 | Influence of beta-lactam antibiotics and ciprofloxacin on cell envelope of Escherichia coli |
| Q39815706 | Influence of beta-lactam antibiotics on serum resistance of K1-positive blood culture isolates of Escherichia coli |
| Q40176406 | Influence of nutrient limitation and low pH on serogroup B Neisseria meningitidis capsular polysaccharide levels: correlation with virulence for mice |
| Q33597462 | Influence of some bacterial and host factors on colonization and invasiveness of Escherichia coli K1 in neonatal rats. |
| Q42496716 | Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation |
| Q54766717 | Isolation of rat immunoglobulin class switch variants of rat-mouse hybridomas by enzyme-linked immunosorbent assay and sequential sublining. |
| Q40177628 | Lipopolysaccharide, capsule, and fimbriae as virulence factors among O1, O7, O16, O18, or O75 and K1, K5, or K100 Escherichia coli. |
| Q28301176 | Localization of the domains of the Haemophilus ducreyi trimeric autotransporter DsrA involved in serum resistance and binding to the extracellular matrix proteins fibronectin and vitronectin |
| Q35399021 | Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo |
| Q26865784 | Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue molecules |
| Q35822024 | Mechanism of resistance to complement-mediated killing of bacteria encoded by the Salmonella typhimurium virulence plasmid gene rck |
| Q37456608 | Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing. |
| Q40147026 | Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. |
| Q39826944 | Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing |
| Q36277444 | NlpI facilitates deposition of C4bp on Escherichia coli by blocking classical complement-mediated killing, which results in high-level bacteremia |
| Q36806314 | O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence |
| Q36998104 | Origins and virulence mechanisms of uropathogenic Escherichia coli |
| Q40150980 | Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1 |
| Q40374186 | Pathogenicity of an Escherichia coli O115:K"V165" mutant negative for F165(1) fimbriae in septicemia of gnotobiotic pigs |
| Q90212156 | Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections |
| Q54464446 | Phenotypic modification of the reactivity in human serum of Escherichia coli K1 isolates. |
| Q57800912 | Phylogenomic analysis of extraintestinal pathogenic ST1193, an emerging multidrug-resistant clonal group |
| Q40553193 | Platelet-borne complement proteins and their role in platelet-bacteria interactions. |
| Q35623872 | Porin polypeptide contributes to surface charge of gonococci |
| Q36277395 | Prc contributes to Escherichia coli evasion of classical complement-mediated serum killing |
| Q74577492 | Relationship between resistance to complement, virulence and outer membrane protein patterns in pathogenic Escherichia coli O2 isolates |
| Q35116000 | Resistance to serum complement, iss, and virulence of avian Escherichia coli |
| Q35145454 | Role of capsule and O antigen in the virulence of uropathogenic Escherichia coli |
| Q34521466 | Role of virulence factors in resistance of avian pathogenic Escherichia coli to serum and in pathogenicity. |
| Q40162311 | Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation |
| Q104503342 | Sialylation acts as a checkpoint for innate immune responses in the central nervous system |
| Q33699784 | Structural and genetic characterization of enterohemorrhagic Escherichia coli O145 O antigen and development of an O145 serogroup-specific PCR assay |
| Q39940174 | Structures of the O1B and O1C lipopolysaccharide antigens of Escherichia coli |
| Q40270274 | Superoxide dismutase and the resistance of Escherichia coli to phagocytic killing by human neutrophils. |
| Q36976544 | Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines. |
| Q47744180 | The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies |
| Q48174563 | The Functional Amyloid Curli Protects Escherichia coli against Complement-Mediated Bactericidal Activity. |
| Q35821829 | The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat |
| Q35501002 | The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli |
| Q35067228 | The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis. |
| Q40153234 | The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli |
| Q37975919 | The role of ATP-binding cassette transporters in bacterial pathogenicity |
| Q33606633 | TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity |
| Q36227866 | TraJ-dependent Escherichia coli K1 interactions with professional phagocytes are important for early systemic dissemination of infection in the neonatal rat. |
| Q27655325 | Two Site-Directed Mutations Are Required for the Conversion of a Sugar Dehydratase into an Aminotransferase § |
| Q35102327 | Vaccination strategies for reducing clinical severity of coliform mastitis |
| Q28468751 | Virulence factors in Escherichia coli urinary tract infection |
| Q54321961 | [Virulence factors and pathophysiology of extraintestinal pathogenic Escherichia coli]. |
Search more.